Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

3 Feb 2022

Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Visualizza Documento

Condividi